| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, R&D And CSO | EVP, R&D And CSO
1 company
Morisset Valerie is an EVP, R&D And CSO at Climb Bio, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $356K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | CLYM Climb Bio, Inc. | EVP, R&D And CSO | Sell | 129,206 | $7.65 | $988,495.44 | -27.3% | -42.3% | -83.1% | |
| Jul 18, 2024 | CLYM Climb Bio, Inc. | EVP, R&D And CSO | Sell | 41,783 | $6.93 | $289,492.05 | -10.4% | -26.0% | -77.7% | |
| Jul 16, 2024 | CLYM Climb Bio, Inc. | EVP, R&D And CSO | Sell | 50,000 | $7.13 | $356,500.00 | -19.8% | -22.9% | -80.2% | |
| Jul 15, 2024 | CLYM Climb Bio, Inc. | EVP, R&D And CSO | Sell | 92,377 | $7.04 | $650,562.77 | -14.4% | -22.2% | -80.4% | |
| Jul 11, 2024 | CLYM Climb Bio, Inc. | EVP, R&D And CSO | Sell | 105,931 | $6.95 | $736,500.46 | -8.2% | -27.0% | -80.6% | |
| Jul 5, 2024 | CLYM Climb Bio, Inc. | EVP, R&D And CSO | Sell | 12,342 | $7.06 | $87,134.52 | -2.7% | -23.1% | -81.0% | |
| Jul 3, 2024 | CLYM Climb Bio, Inc. | EVP, R&D And CSO | Sale+OE | 50,000 | $6.76 | $338,000.00 | -9.7% | -24.8% | -81.3% |